Opna Immuno-Oncology SA — Form D
Opna Immuno-Oncology SA of ST SULPICE, V8, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-09. Industry: Biotechnology.
Offering
- Filed: 2021-02-09
- Form: D
- Accession: 0001844923-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-388869
Issuer
- Name: Opna Immuno-Oncology SA
- CIK: 0001844923
- Entity type: Corporation
- Jurisdiction: SWITZERLAND
- Incorporated: 2020
- Address: CHEMIN DES CHARMILLES 34, ST SULPICE, V8, 1025
- Phone: 41798479785
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Gideon W Bollag | Director | Orinda, CA |
| Douglas Hanahan | Director | St Sulpice, V8 |
| Brian W Pusch | Director | New York, NY |
| Joseph W Schlessinger | Director | Woodbridge, CT |
More